|
Between January 1 and May 30 of 2004, Bristol-Myers Squibb spent about $35 million on advertising Plavix, a blood thinner. In the first three months of 2004, the price charged by manufacturers to wholesalers for Plavix rose by 7.9%. Bristol-Myers spent about $7.2 million in the first five months of 2004 to advertise Pravachol, a cholesterol-lowering drug. It rose in price in the first quarter by 7.0%.
Merck spent $42 million to advertise Zocor, another cholesterol-lowering drug, during the first five months of the year. Although the price charged to wholesalers in the first quarter remained steady, between 1999 and 2003, it rose 25.8%.
|
Printer-friendly format
Email this thread to a friend
Bookmark this thread
(1000+ posts)
Send PM |
Profile |
Ignore
